129 related articles for article (PubMed ID: 2795434)
1. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
[TBL] [Abstract][Full Text] [Related]
2. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
3. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
4. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
5. Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum.
Naganuma A; Satoh M; Yokoyama M; Imura N
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):127-34. PubMed ID: 6685904
[TBL] [Abstract][Full Text] [Related]
6. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
[TBL] [Abstract][Full Text] [Related]
7. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
8. Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with Ehrlich ascites tumor cell.
Naganuma A; Satoh M; Imura N
J Pharmacobiodyn; 1984 Mar; 7(3):217-20. PubMed ID: 6540302
[TBL] [Abstract][Full Text] [Related]
9. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of selenium intake enhances manifestation of renal toxicity of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
Toxicol Lett; 1987 Sep; 38(1-2):155-60. PubMed ID: 3629626
[TBL] [Abstract][Full Text] [Related]
11. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic index of cisplatin by procaine hydrochloride.
Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A
J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610
[TBL] [Abstract][Full Text] [Related]
13. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
Grossie VB; Valdivieso M; Drewinko B; Loo TL
Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenite on the toxicity of cis-DDP in mice: estimation of trace elements.
Shenberg C; Izak-Biran T; Mantel M; Rachmiel B; Weininger J; Chaitchik S
J Trace Elem Electrolytes Health Dis; 1989 Jun; 3(2):71-5. PubMed ID: 2562498
[TBL] [Abstract][Full Text] [Related]
15. Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Imura N; Naganuma A; Satoh M; Koyama Y
Experientia Suppl; 1987; 52():655-60. PubMed ID: 2959559
[TBL] [Abstract][Full Text] [Related]
16. Reduction of cisplatinum-induced renal toxicity in mice by tetrahydroindazolonecarboxylic acid (HIDA) [corrected].
Radacic M; Overgaard J; Skaric D; Skaric V; Horsman M
Acta Oncol; 1993; 32(1):53-6. PubMed ID: 8466764
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Shimada H; Takahashi K; Funakoshi T; Kojima S
Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
[TBL] [Abstract][Full Text] [Related]
18. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
19. Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia.
Esposito M; Vannozzi MO; Viale M; Pellecchia C; Merlo F; Cadoni A; Cafaggi S; Parodi B; Lerza R; Poirier MC
Anticancer Res; 1993; 13(5A):1511-6. PubMed ID: 8239529
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1988; 21(2):176-8. PubMed ID: 3349566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
